Search Results 361-370 of 18222 for Immunode

1. A Study Of Ritlecitinib In Adults With Hidradenitis Suppurativa, Or HS - Mayo Clinic

   Have a known immunodeficiency disorder (including positive serology for HIV at screening) or a first-degree relative with a hereditary immunodeficiency (unless ...

2. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

   * Immunocompromised patients including patients known to be human immunodeficiency virus (HIV) positive or those on chronic steroids * Note: Must be off ...

3. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   History of active primary immunodeficiency including, but not limited to acquired immune deficiency syndrome (AIDS) based upon current CDC definition; Note ...

4. Study Of SIM0500 Alone In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   Known human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS). 4. Participant is pregnant or breastfeeding, or expecting ...

5. Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   History of active primary immunodeficiency;; Known history of previous tuberculosis;; Active infection including hepatitis B, hepatitis C or human ...

6. Immune Dysfunction in Autoimmune Disease - Mayo Clinic

   Persnal or family Hx of immunodeficiency. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 6/04/2024. Questions ...

7. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Known human immunodeficiency virus (HIV) infection; HBsAg positive; Hepatitis C virus (HCV) antibody positive; Use of moderate/strong cytochrome P450 (CYP)3A4 ...

8. Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055) - Mayo Clinic

   Human immunodeficiency virus (HIV); Hepatitis B or C; Received live vaccine within 30 days of planned start of study therapy. Participating Mayo Clinic ...

9. Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer - Mayo Clinic

   Known active human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS) related illness, or hepatitis B or C infection. Administration of ...

10. Interstitial Lung Disease Clinical Trials - Mayo Clinic Research

    There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency ( ...